---
category: listing
circular_id: 2f8928053e1f73bf
date: '2026-02-26'
description: BSE announces the upcoming listing of equity shares of Gaudium IVF and
  Women Health Limited (scrip code 544709, symbol GAUDIUMIVF) on the Exchange. The
  exact listing date will be communicated via a separate notice.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={AEC56AC0-BC84-42A1-AE5E-78E9664C9338}&noticeno=20260226-7&dt=02/26/2026&icount=7&totcount=47&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Standard new equity listing notice for a healthcare company; date of
  listing is yet to be announced via separate notice, limiting immediate trading impact.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20260226-7&attachedId=
processing:
  attempts: 1
  content_hash: 8ae02db9af1f59ac
  processed_at: '2026-02-26T16:19:16.287481'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-02-26T09:35:40+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={AEC56AC0-BC84-42A1-AE5E-78E9664C9338}&noticeno=20260226-7&dt=02/26/2026&icount=7&totcount=47&flag=0
severity: medium
source: bse
stocks:
- GAUDIUMIVF
tags:
- listing
- equity
- ipo
- gaudiumivf
- healthcare
- ivf
- new-listing
title: Listing of Equity Shares of Gaudium IVF and Women Health Limited
---

## Summary

BSE has issued Notice No. 20260226-7 informing trading members that the equity shares of Gaudium IVF and Women Health Limited will be listed and admitted to dealings on BSE. The exact date of listing will be communicated through a separate notice.

## Key Points

- Gaudium IVF and Women Health Limited is being listed on BSE under the Equity segment.
- Scrip Code: 544709
- Trading Symbol: GAUDIUMIVF
- ISIN: INE0P8B01020
- The listing date and full security details will be announced in a subsequent notice.

## Regulatory Changes

No regulatory changes introduced. This is a standard listing admission notice under BSE's existing listing framework.

## Compliance Requirements

Trading members are advised to take note of the upcoming listing. Further operational details (lot size, price band, etc.) will be provided in the follow-up notice prior to the listing date.

## Important Dates

- Notice Date: February 26, 2026
- Listing Date: To be announced via a separate notice.

## Impact Assessment

This circular signals the imminent debut of Gaudium IVF and Women Health Limited on BSE. As a healthcare company focused on IVF and women's health, it may attract interest from investors in the healthcare and fertility sector. The actual market impact will be assessable once the listing date and price details are confirmed in the follow-up notice.